Urology News and Research

Latest Urology News and Research

Specific dopamine system gene variants linked to ADHD medication response in children

Children with certain dopamine system gene variants have an improved response to methylphenidate - the most commonly prescribed medication for Attention Deficit Hyperactivity Disorder - in a finding that could help eliminate the guesswork from prescribing effective medications for children with ADHD.

22 Oct 2011

Watson receives FDA approval for Androderm lower-dose formulations

Watson Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration approved its Androderm (testosterone transdermal system) 2 mg and 4 mg formulation.

21 Oct 2011

AAHPO honors BMC physician for medical contributions in the U.S., Armenia

Richard Babayan, MD, was honored recently by the Armenian American Health Professional Organization (AAHPO) for his exceptional contributions to medicine in both the United States and in Armenia.

21 Oct 2011

TJUH offers new optical imaging agent for bladder cancer detection

Thomas Jefferson University Hospital is one of a select number of medical centers nationwide—and currently the only one in the Northeast—offering a newly approved optical imaging agent for the detection of papillary cancer of the bladder in patients with known or suspected bladder cancer.

21 Oct 2011

Older men more likely to die from prostrate cancer

Contrary to common belief, men age 75 and older are diagnosed with late-stage and more aggressive prostate cancer and thus die from the disease more often than younger men, according to a University of Rochester analysis published online this week by the journal, Cancer.

20 Oct 2011

Many Americans do not have access to a 'medical home'

Many Americans do not have access to a "medical home"-a physician practice that is able to manage ongoing care for patients and coordinate care among specialists and other health care facilities, according to a University of Michigan Health System-led study.

19 Oct 2011

Dendreon initiates enrollment in DN24-02 Phase 2 trial for HER2 positive cancer

Dendreon Corporation today announced that the company has begun enrolling patients into a Phase 2 trial for DN24-02, Dendreon's investigational active cellular immunotherapy being evaluated for the treatment of HER2 positive cancer.

18 Oct 2011

Watson confirms patent challenge of generic Daytrana

Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Methylphenidate Transdermal System, 10 mg/9 hrs, 15 mg/9 hrs, 20 mg/9 hrs, and 30 mg/9 hrs.

15 Oct 2011

EMKinetics initiates TranStim therapy pivotal trial for urge incontinence, overactive bladder

EMKinetics, Inc. announced today initiation of the TranStim Transdermal Neuromodulation System pivotal trial for patients suffering from urge incontinence and overactive bladder.

14 Oct 2011

University of Cape Town, UT Southwestern sign affiliation agreement

UT Southwestern Medical Center and the faculty of health sciences of the University of Cape Town in South Africa, signed a five-year affiliation agreement today to collaborate on faculty and student exchanges, joint research and training activities and other educational opportunities.

13 Oct 2011

High dose vitamin E supplements may raise risk of prostate cancer: Study

The chances of developing the disease rose by 17 per cent, even years after men stopped taking the vitamin, claim researchers. This comes right after the study which found women taking multivitamins and other supplements have an increased risk of dying.

13 Oct 2011

PSA test for prostate cancer may confuse: Experts debate its continued use

According to new research the PSA test for prostate cancer does more harm than good. This week, the United States Preventive Services Task Force is expected to announce its recommendation against routine testing for blood levels of prostate-specific antigen, the protein that can be a signal of prostate cancer.

11 Oct 2011

Selected prescription drugs contribute to 10% of lower urinary tract symptoms among men

Use of selected prescription medications, including antidepressants, antihistamines, bronchodilators, anticholinergics, sympathomimetics, and diuretics contribute to 10 percent of lower urinary tract symptoms among men according to a Kaiser Permanente study published in the Archives of Internal Medicine.

11 Oct 2011

LUGPA encourages men to speak out to preserve prostate cancer screenings

The Large Urology Group Practice Association (LUGPA), representing more than 1,800 urologists, encourages men to speak out to preserve prostate cancer screenings.

11 Oct 2011

USPSTF releases draft recommendation on prostate cancer screening

Yesterday, the United States Preventive Services Task Force released a draft recommendation that states healthy men should no longer receive a P.S.A test for prostate cancer as it often leads to unnecessary testing and procedures and does not save lives.

10 Oct 2011

Hassenfeld family, NYU Langone unveil $50M gift to create new pediatric hospital

NYU Langone Medical Center and the Hassenfeld family unveiled a $50 million gift today that will create a comprehensive pediatric hospital at NYU Langone Medical Center.

3 Oct 2011

MDC Partners acquires majority stake in Concentric Pharma

Concentric Pharma Advertising, one of the largest and fastest-growing healthcare advertising agencies in the country, announced today that MDC Partners, Inc., has acquired a majority stake in the company.

1 Oct 2011

Lifespan researcher receives Ig Nobel Prize at Harvard University

Peter J. Snyder, Ph.D., vice president of research for Lifespan, received one of 10 Ig Nobel Prize awards during the annual ceremony last night at Harvard University.

1 Oct 2011

Kimmel Cancer Center at Jefferson celebrates two decades of caring and collaboration to beat cancer

From October forward, the Kimmel Cancer Center at Jefferson (KCC), a National Cancer Institute-designated cancer center, is celebrating 20 years of service to the community and the groundbreaking cancer research from the scientists and physicians who've provided an invaluable contribution to medical science and healthcare.

30 Sep 2011

Saw Palmetto ineffective in patients with enlarged prostate: Study

A new study showed that much cited saw-palmetto supplements for the middle aged to cope with the symptoms of an enlarged prostate might not do much at all.

28 Sep 2011